Skip to content

Clinical trials

Acute Coronary Syndrome trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Country / region: Czechia Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20083
20097
20105
20141
20153
20161
20181
20201
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
AstraZeneca2
Bristol-Myers Squibb2
Eli Lilly and Company2
Janssen Research & Development, LLC2
The Medicines Company2
Abcentra1
Anthera Pharmaceuticals1
Astellas Pharma Europe B.V.1
Baim Institute for Clinical Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome26
Myocardial Infarction9
Coronary Artery Disease5
Heart Diseases5
Angina, Unstable4
Cardiovascular Diseases4
Non-ST Elevated Myocardial Infarction4
ST Elevation Myocardial Infarction4
Myocardial Ischemia3
Stroke3

Trials

Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.